• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC271000
Device Problem Break (1069)
Patient Problem No Patient Involvement (2645)
Event Date 01/20/2020
Event Type  malfunction  
Manufacturer Narrative
The review of the manufacturing paperwork verified that this lot met all pre-release specifications.The device was not returned for evaluation.The evaluation was completed using a picture of the device provided.The device evaluation showed the following: the delivery catheter was broken at the trailing olive.The leading end had fractured at the trailing olive.The device was deployed off the delivery catheter.The findings from the evaluation are consistent with the physician¿s observations.The cause for the catheter breakage could not be determined with the available information.The version of the ifu in place at the time of the implant provided the following potentially relevant warnings: the gore® excluder® aaa endoprosthesis instructions for use (ifu) clearly states: do not advance the device outside of the sheath.The sheath will protect the device from catheter breakage or premature deployment while tracking it into position.Do not rotate the contralateral leg delivery catheter during delivery, positioning or deployment.Catheter breakage or premature deployment may occur.Do not continue to withdraw the delivery catheter if resistance is felt during removal through the introducer sheath.Forcibly withdrawing the delivery catheter through the introducer sheath when resistance is encountered has resulted in adverse events including catheter separation and reintervention.
 
Event Description
It was reported that the patient presented with an abdominal aortic aneurysm and was treated with gore® excluder® aaa endoprostheses.After the gore® excluder® contralateral leg device was successfully implanted, the catheter was removed through the valve of the used gore® dryseal flex sheath (dsf).During the removal through the valve, some resistance was felt and it appeared that the leading end separated from the device catheter.The catheter and the broken leading end were removed from the sheath and the procedure was completed successfully with no reported issues to the patient.
 
Manufacturer Narrative
Updated g1 g9: please note, the device was manufactured in a different facility than originally reported and the site number should be 3013164176.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9716506
MDR Text Key191176507
Report Number2953161-2020-00003
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132618538
UDI-Public00733132618538
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 06/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/07/2022
Device Model NumberPLC271000
Device Catalogue NumberPLC271000
Device Lot Number21184194
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/17/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age58 YR
-
-